Acumen Pharmaceuticals OverviewAcumen Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ABOS.
Quarterly Other Income/Expense
$412000.00
↓ 73.82% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$1.33M
↓ 87.12% YoY
Trailing 12 months ending Mar 31, 2026